Similar Posts
Can Coffee Slow Prostate Cancer Growth?
New research has suggested that two substances found in coffee may help slow prostate cancer growth. This study is just one many that have looked at the impact of one or more cups of java on prostate cancer. What’s in coffee? Experts report that coffee contains more than 2,500 nonvolatile and volatile compounds. The concentrations…
Can I Take Xofigo after Provenge?
Taking Xofigo after Provenge could potentially be a treatment sequence for metastatic prostate cancer, after more research has been done. With all of the different clinical trials in castration resistant prostate cancer and the approval of multiple different different drugs, some patients might wonder if they can take Xofigo after Provenge. Unfortunately, there is not…
Extra Weight Increases Prostate Cancer Risk
Researchers have found that extra weight increases prostate cancer risk, and it also can result in a more aggressive and deadly form of the disease. That’s the consensus among the authors of a recent article appearing in Cancer. Fat and prostate cancer risk As men age and testosterone levels decline, there’s a tendency to accumulate…
Focal Laser Ablation Therapy Update from NIH
Dr. Peter Pinto is one of the most respected urologic researchers in America. He is the Head of the Prostate Cancer Section of the Urologic Oncology Branch of the Center for Cancer Research (National Cancer Institute/National Institutes of Health). That’s a very long formal title for a man who is humble, personable and good-natured. His…
Some Prostate Drugs Can Delay Cancer Diagnosis
How would you feel if you were taking prescribed drugs for enlarged prostate and you found out years later they had masked a diagnosis of prostate cancer? The authors of a new study have reported that men who take medications for benign prostatic hyperplasia (BPH) may have a false sense of security because the prostate…
Can Provenge Be Used For Early Stage Prostate Cancer
Provenge for early stage prostate cancer is not the approved use of this drug. In fact, when the immunotherapy Provenge (sipuleucel-T) was approved by the Food and Drug Administration (FDA) in 2010, it was limited to treatment of late stage prostate cancer. Specifically, it is for men with asymptomatic or minimally symptomatic metastatic prostate cancer that…